Indeed, therapeutic strategies using miRNAs have been explored in other cancer types; for example, in cisplatin-resistant lung cancer, bone-marrow mesenchymal stem-cell-derived exosomes shuffle miR-193a has been shown to downregulate LRRC1, thus inhibiting the proliferation, colony formation, invasion, and migration of tumor cells, while promoting apoptosis [44]. This evidence concerns the gene LRRC1 and lung carcinoma.